SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,375.27 |
Enterprise Value ($M) | 1,364.98 |
Book Value ($M) | -78.82 |
Book Value / Share | -0.26 |
Price / Book | -17.45 |
NCAV ($M) | -204.35 |
NCAV / Share | -0.67 |
Price / NCAV | -6.73 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.37 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.94 |
Current Ratio | 3.28 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 268.31 |
Assets | 393.84 |
Liabilities | 472.66 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 285.50 |
Operating Income | 68.68 |
Net Income | 27.59 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 42.51 |
Cash from Investing | -96.65 |
Cash from Financing | -137.27 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
129,865 | 1,094,917 | 11.86 | |
168,084 | 1,890,707 | 8.89 | |
193,951 | 1,078,689 | 17.98 | |
163,373 | 1,610,354 | 10.15 | |
(click for more detail) |
Similar Companies | |
---|---|
LXEO – Lexeo Therapeutics, Inc. | MDWD – MediWound Ltd. |
MIRM – Mirum Pharmaceuticals, Inc. | MNOV – MediciNova, Inc. |
MRUS – Merus N.V. |